Cabaletta Bio Files 8-K with Exhibits
Ticker: CABA · Form: 8-K · Filed: Apr 20, 2026 · CIK: 0001759138
| Field | Detail |
|---|---|
| Company | Cabaletta Bio, Inc. (CABA) |
| Form Type | 8-K |
| Filed Date | Apr 20, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, exhibits
Related Tickers: CABA
TL;DR
Cabaletta Bio dropped an 8-K on 4/20/26, check the exhibits for deets.
AI Summary
Cabaletta Bio, Inc. filed an 8-K on April 20, 2026, reporting other events and financial statements. The filing includes various exhibits, such as the main 8-K document and supplemental information in EX-99.1, along with numerous graphic files.
Why It Matters
This 8-K filing indicates that Cabaletta Bio is providing updated information or disclosures to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and corporate actions.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting other events and exhibits, not indicating any immediate material adverse changes.
Key Numbers
- 2026-04-20 — Filing Date (Date the 8-K was filed and accepted by the SEC.)
Key Players & Entities
- Cabaletta Bio, Inc. (company) — Filer of the 8-K
- 0001759138 (company) — CUSIP number for Cabaletta Bio, Inc.
- 0001759138-26-000016 (filing_id) — SEC Accession Number for the 8-K filing
FAQ
What specific 'Other Events' are detailed in Item 8.01 of this 8-K filing?
The provided text does not specify the content of Item 8.01, only that it is an 'Other Events' section.
What is the purpose of the numerous graphic files listed as exhibits?
The filing lists many graphic files (e.g., caba-ex99_1s1.jpg) as exhibits, but their specific content or purpose is not detailed in the provided text.
What information is contained within the EX-99.1 exhibit?
The provided text identifies EX-99.1 as an exhibit but does not describe its content.
Does this 8-K filing include any financial statements?
Yes, Item 9.01 indicates that 'Financial Statements and Exhibits' are included, though the specific statements are not detailed in the provided text.
What is the significance of the filing date April 20, 2026?
This is the date Cabaletta Bio, Inc. officially filed the 8-K report with the SEC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 20, 2026 regarding Cabaletta Bio, Inc. (CABA).